In the present study, all participants had normal ALT/AST levels prior to first starting MTX treatment, but the L/S ratios on HRCT scans at that time suggested the presence of underlying fatty liver in patients who developed NASH-like lesions during MTX treatment. Here, GPT is linked to fatty liver disease.